Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety
- PMID: 30837807
- PMCID: PMC6397008
- DOI: 10.5863/1551-6776-24.1.4
Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety
Abstract
An underappreciated problem in child health is the risk for adverse drug reactions (ADRs). While there is an impression that children are at a lower risk than adults for ADRs, in fact a number of factors germane to pediatric therapy place certain groups of children at a high risk for adverse events associated with therapy. Given the importance of drug safety, an understanding of a diagnostic classification for ADRs and of how to approach a possible ADR clinically are key skills for pediatric pharmacists. As drug therapy for children evolves, becomes more complex, and begins to use novel molecules and biologicals there will be an increasing need for pediatric pharmacists to be more involved in clinical care, education, and research specific to drug safety.
Conflict of interest statement
Disclosures The author declares no conflict or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medication, employment, gifts, and honoraria.
Similar articles
-
Monitoring drug safety in Astrakhan, Russia.Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680. Int J Risk Saf Med. 2015. PMID: 26639700
-
A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.Drug Saf. 2000 Aug;23(2):165-72. doi: 10.2165/00002018-200023020-00006. Drug Saf. 2000. PMID: 10945377
-
A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.Int J Clin Pharm. 2016 Feb;38(1):80-7. doi: 10.1007/s11096-015-0209-x. Int J Clin Pharm. 2016. PMID: 26499501
-
Pilot testing of checklists to discern adverse drug reactions and adverse drug events.J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):61-9. doi: 10.1331/JAPhA.2013.11196. J Am Pharm Assoc (2003). 2013. PMID: 23636158 Review.
-
The role of hospital and community pharmacists in pharmacovigilance.Res Social Adm Pharm. 2005 Mar;1(1):126-33. doi: 10.1016/j.sapharm.2004.12.009. Res Social Adm Pharm. 2005. PMID: 17138470 Review.
Cited by
-
Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care.Clin Pharmacokinet. 2022 Dec;61(12):1705-1717. doi: 10.1007/s40262-022-01181-8. Epub 2022 Nov 11. Clin Pharmacokinet. 2022. PMID: 36369327 Free PMC article.
-
Digital Technology Applications in the Management of Adverse Drug Reactions: Bibliometric Analysis.Pharmaceuticals (Basel). 2024 Mar 19;17(3):395. doi: 10.3390/ph17030395. Pharmaceuticals (Basel). 2024. PMID: 38543181 Free PMC article.
-
Risk Factors Associated With Drug-Related Side Effects in Children: A Scoping Review.Glob Pediatr Health. 2024 Aug 27;11:2333794X241273171. doi: 10.1177/2333794X241273171. eCollection 2024. Glob Pediatr Health. 2024. PMID: 39205860 Free PMC article.
-
Diagnosing Single and Multiple Drug Hypersensitivity in Children: A Tertiary Care Center Retrospective Study.Children (Basel). 2022 Dec 12;9(12):1954. doi: 10.3390/children9121954. Children (Basel). 2022. PMID: 36553397 Free PMC article.
-
Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital.PLoS One. 2021 Jan 13;16(1):e0245368. doi: 10.1371/journal.pone.0245368. eCollection 2021. PLoS One. 2021. PMID: 33439905 Free PMC article.
References
-
- Rieder MJ. If children ruled the pharmaceutical industry: the need for pediatric formulations. Drug News Perspect. 2010;23(7):458–464. - PubMed
-
- Weinshilboum RM. The therapeutic revolution. Clin Pharmacol Ther. 1987;42(2):481–484. - PubMed
-
- Thomas L. The Youngest Science: Notes of a Medicine Watcher. London, England: Penguin Books; 1995.
-
- Rieder MJ. Pathophysiology of drug hypersensitivity: implications for therapy. Expert Opin Drug Safety. 2009;8:331–343. - PubMed
-
- Ballentine C. Sulfanilamide Disaster. FDA Consumer magazine June 1981 Issue at https://www.fda.gov/aboutfda/whatwedo/history/productregulation/sulfanil... Accesseb November 19, 2018.
LinkOut - more resources
Full Text Sources
Research Materials